Treatment Efficacy of a Dual Release of Aflibercept and Dexamethasone From a Single Hydrogel Drug Delivery System in a Rodent Model
Translational Vision Science & Technology · 2025
DOI: 10.1167/tvst.14.6.31 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Vision Science & Technology, 2025. Verfasst von Kayla M Rudeen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA. Hauptthemen laut MEDLINE: Receptors, Vascular Endothelial Growth Factor, Dexamethasone, Recombinant Fusion Proteins, Choroidal Neovascularization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS.
Abstract (Originalsprache)
Purpose
Age-related macular degeneration (AMD) is the leading cause of vision loss for the elderly population. Wet AMD, which accounts for approximately 15% of AMD cases, is characterized by abnormal blood vessel growth from the choroid into the subretinal space. Although intravitreal anti-vascular endothelial growth factor (VEGF) agents have become the standard of care for wet AMD, there is a growing subset of patients who do not fully respond to monotherapy anti-VEGF treatment. In previously published reports, corticosteroids have shown improvements in treatment efficacy when administered with anti-VEGF in a subset of non-responders to anti-VEGF monotherapy.
Methods
A combination dexamethasone and aflibercept drug delivery system (Combo-DDS) was evaluated in a laser-induced rodent model of choroidal neovascularization (CNV). Longitudinal monitoring was done through week 22 using fluorescein angiography (FA) and spectral domain optical coherence tomography (SD-OCT). Multi-Otsu thresholding was used to quantify the lesion area based on late-phase FA images. In addition, preliminary safety and biocompatibility of the Combo-DDS were evaluated by intraocular pressure (IOP) measurements, electroretinogram (ERG), and histology (n = 6 eyes/group).
Results
In the laser-induced CNV model, CNV lesions (n = 28-36 lesions/group) were monitored longitudinally. Combo-DDS showed a regression in lesion size starting at week 2 that continued through the end of study. IOP, ERG, and histology showed preliminary safety and biocompatibility of the Combo-DDS.
Conclusions
This study demonstrated that Combo-DDS maintained treatment efficacy in a laser-induced CNV rodent model for 6 months. Translational Relevance: The Combo-DDS shows the potential to eliminate the need for separate dosing regiments of anti-VEGF and corticosteroids for non-responders to anti-VEGF monotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA.
- Local Delivery Translational Sciences, AbbVie, North Chicago, IL, USA.
- Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA.
- Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois, Chicago, IL, USA.
- Department of Biomedical Engineering, Stevens Institute of Technology, Hoboken, NJ, USA.
Förderung
- NEI NIH HHS
Zitieren
APA
Rudeen, K. M., Maloney, C. M., Lydon, K. L., Teixeria, L. B. C., Mieler, W. F., & Kang-Mieler, J. J. (2025). Treatment Efficacy of a Dual Release of Aflibercept and Dexamethasone From a Single Hydrogel Drug Delivery System in a Rodent Model. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.14.6.31
Vancouver
Rudeen KM, Maloney CM, Lydon KL, Teixeria LBC, Mieler WF, Kang-Mieler JJ. Treatment Efficacy of a Dual Release of Aflibercept and Dexamethasone From a Single Hydrogel Drug Delivery System in a Rodent Model. Translational Vision Science & Technology. 2025. doi:10.1167/tvst.14.6.31
BibTeX
@article{Rudeen2025,
author = {Rudeen, Kayla M and Maloney, Chryssa M and Lydon, Katherine L and Teixeria, Leandro B C and Mieler, William F and Kang-Mieler, Jennifer J},
title = {Treatment Efficacy of a Dual Release of Aflibercept and Dexamethasone From a Single Hydrogel Drug Delivery System in a Rodent Model},
journal = {Translational Vision Science & Technology},
year = {2025},
doi = {10.1167/tvst.14.6.31}
}
EUVIMED